Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Epigenomics Shareholders Equity (Quarterly): 2.075M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.075M |
| March 31, 2023 | 4.954M |
| December 31, 2022 | 10.91M |
| September 30, 2022 | 13.69M |
| June 30, 2022 | 17.41M |
| March 31, 2022 | 21.30M |
| December 31, 2021 | 25.04M |
| September 30, 2021 | 28.11M |
| June 30, 2021 | 7.570M |
| March 31, 2021 | 7.595M |
| December 31, 2020 | 4.753M |
| September 30, 2020 | 6.509M |
| June 30, 2020 | 8.229M |
| March 31, 2020 | 6.918M |
| December 31, 2019 | 10.79M |
| September 30, 2019 | 9.765M |
| June 30, 2019 | 13.31M |
| March 31, 2019 | 17.73M |
| December 31, 2018 | 21.29M |
| September 30, 2018 | 2.762M |
| June 30, 2018 | 5.827M |
| March 31, 2018 | 9.475M |
| December 31, 2017 | 12.69M |
| September 30, 2017 | 15.32M |
| June 30, 2017 | 9.688M |
| Date | Value |
|---|---|
| March 31, 2017 | 13.11M |
| December 31, 2016 | 15.25M |
| September 30, 2016 | 7.684M |
| June 30, 2016 | 10.28M |
| March 31, 2016 | 5.860M |
| December 31, 2015 | 7.760M |
| September 30, 2015 | 8.322M |
| June 30, 2015 | 9.709M |
| March 31, 2015 | 4.733M |
| December 31, 2014 | 7.428M |
| September 30, 2014 | 3.838M |
| June 30, 2014 | 6.720M |
| March 31, 2014 | 9.281M |
| December 31, 2013 | 8.919M |
| September 30, 2013 | 5.143M |
| June 30, 2013 | 6.991M |
| March 31, 2013 | 8.924M |
| December 31, 2012 | 5.498M |
| September 30, 2012 | 8.939M |
| June 30, 2012 | 13.24M |
| March 31, 2012 | 18.65M |
| December 31, 2011 | 20.97M |
| September 30, 2011 | 28.01M |
| June 30, 2011 | 37.05M |
| March 31, 2011 | 40.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.075M
Minimum
Jun 2023
28.11M
Maximum
Sep 2021
11.70M
Average
9.765M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 63.90M |
| InflaRx NV | 102.33M |
| MorphoSys AG | 54.22M |
| BioNTech SE | 21.56B |
| Immatics NV | 432.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.583M |
| Total Liabilities (Quarterly) | 2.508M |
| Current Ratio | 1.934 |